Scientists at the Barshop Institute for Longevity and Aging Studies are testing the therapeutic qualities of rapamycin on age-related diseases and health span, thanks to a $5.2 million grant awarded by the National Institute on Aging. To better understand the broader physiological effects of rapamycin, a team of 21 scientists will investigate the anti-aging effectiveness of rapamycin on various biological systems in aging mice.
